Yahoo Web Search

  • FirefoxTry Yahoo Search on Firefox »
    1. Second Sight is currently conducting a trial to test the safety and utility of the Argus II in individuals with Dry Age-Related Macular Degeneration. Second Sight is also developing ...

    2. And as the population ages, we're seeing a greater prevalence of eye disorders, such as diabetic retinopathy and macular degeneration. We're also in the second year of our 3-year ...

    3. To learn more about pSivida please visit www.psivida.com and connect on Twitter, LinkedIn, Facebook and Google+. SAFE HARBOR STATEMENTS ...

    4. Thanks to these preliminary efficacy and safety data, the company has initiated 3 development programs based on various antibody formats to: Counteract pathological vascular proliferation (anti-angiogenic ...

    5. Cell Carcinoma (Urothelial Cell Carcinoma), Ureter Cancer, Urethral Cancer, Wet (Neovascular / Exudative) Macular Degeneration and Wilms' Tumor (Nephroblastoma). The latest report ...

    1. 1234545 results